Class Action Reminder for APLT Investors: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Securities Fraud Class Action Lawsuit
StockNews.AI · 437 days
High Materiality10/10
AI Summary
A securities class action lawsuit has been filed against Applied Therapeutics. The lawsuit covers purchases made from January 3, 2024, to December 2, 2024. Allegations include misleading statements regarding trial protocol for govorestat. Failure to follow proper protocol poses risks for FDA New Drug Application. Investors can become lead plaintiffs until February 18, 2025.
Sentiment Rationale
The lawsuit indicates possible fraud, impacting investor trust and stock price.
Trading Thesis
Legal issues typically affect stock prices swiftly following announcement.
Market-Moving
- A securities class action lawsuit has been filed against Applied Therapeutics.
- The lawsuit covers purchases made from January 3, 2024, to December 2, 2024.
- Allegations include misleading statements regarding trial protocol for govorestat.
Key Facts
- A securities class action lawsuit has been filed against Applied Therapeutics.
- The lawsuit covers purchases made from January 3, 2024, to December 2, 2024.
- Allegations include misleading statements regarding trial protocol for govorestat.
- Failure to follow proper protocol poses risks for FDA New Drug Application.
- Investors can become lead plaintiffs until February 18, 2025.
Companies Mentioned
- APLT (APLT)
Legal
The lawsuit directly affects APLT's reputation and market perception, leading to potential losses.